Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure by Barbagallo, Federica et al.
931
In animal hearts, elevated sympathetic activity stimulates the β-adrenergic signal to promote inotropy and lusitropy 
via the concerted protein kinase A (PKA) phosphorylation 
of substrates at multiple subcellular locations. PKA is spa-
tially and temporally regulated through a set of A-kinase 
anchoring protein complexes.1 As a result, the precise PKA 
phosphorylation of myofilament proteins, such as cardiac 
troponin I (TnI) and myosin-binding protein C, and Ca2+-
handling proteins, such as phospholamban (PLB) and ry-
anodine receptor on the sarcoplasmic reticulum (SR), is 
necessary to co-ordinate positive inotropic and lusitropic 
cardiac effects.2,3
Chronic adrenergic signaling also promotes structural 
and functional remodeling in the myocardium, which con-
tributes to cardiac hypertrophy and eventually heart failure 
in a variety of clinical conditions. A desensitized cardiac β 
adrenergic receptor (βAR) signaling pathway,4 a hallmark 
of the failing heart, is associated with a reduced number of 
β1AR- but not β2AR-binding sites at the plasma membrane 
(PM). As a consequence, diminished βAR signaling may lead 
to lower PKA-mediated protein phosphorylation after adren-
ergic stimulation.5 The disturbed βAR signaling and reduced 
PKA phosphorylation result in blunted contractile response 
after administration of βAR agonists.6 Interestingly, recent 
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Rationale: In heart failure, myofilament proteins display abnormal phosphorylation, which contributes to contractile 
dysfunction. The mechanisms underlying the dysregulation of protein phosphorylation on myofilaments is not 
clear.
Objective: This study aims to understand the mechanisms underlying altered phosphorylation of myofilament 
proteins in heart failure.
Methods and Results: We generate a novel genetically encoded protein kinase A (PKA) biosensor anchored onto the 
myofilaments in rabbit cardiac myocytes to examine PKA activity at the myofilaments in responses to adrenergic 
stimulation. We show that PKA activity is shifted from the sarcolemma to the myofilaments in hypertrophic failing 
rabbit myocytes. In particular, the increased PKA activity on the myofilaments is because of an enhanced β2 
adrenergic receptor signal selectively directed to the myofilaments together with a reduced phosphodiesterase 
activity associated with the myofibrils. Mechanistically, the enhanced PKA activity on the myofilaments is associated 
with downregulation of caveolin-3 in the hypertrophic failing rabbit myocytes. Reintroduction of caveolin-3 in the 
failing myocytes is able to normalize the distribution of β2 adrenergic receptor signal by preventing PKA signal 
access to the myofilaments and to restore contractile response to adrenergic stimulation.
Conclusions: In hypertrophic rabbit myocytes, selectively enhanced β2 adrenergic receptor signaling toward 
the myofilaments contributes to elevated PKA activity and PKA phosphorylation of myofilament proteins. 
Reintroduction of caveolin-3 is able to confine β2 adrenergic receptor signaling and restore myocyte contractility 
in response to β adrenergic stimulation.  (Circ Res. 2016;119:931-943. DOI: 10.1161/CIRCRESAHA.116.308964.)
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progress suggests that βAR can continuously signal both at 
the cell surface7 and after catecholamine-induced endocyto-
sis.8 These βAR signals may play a role in adaptive cardiac 
hypertrophic remodeling and promote compensatory contrac-
tility in the heart. Until now, it remains poorly understood how 
remodeling of βAR signaling affects PKA activity in different 
subcellular locations for PKA-dependent phosphorylation of 
substrates in failing myocytes.
Recent efforts have been put forward to understand β-
adrenergic signaling at the sarcolemma and the SR because of 
their essential roles in calcium handling and arrhythmia in car-
diac diseases. By using genetically encoded biosensors, stud-
ies show that adrenergic-induced PKA activity at the SR can 
be selectively inhibited by chronic insulin9 and the proinflam-
matory factor, prostaglandin E,10 both of which are elevated in 
clinical conditions associated with heart failure. Moreover, in 
hypertrophic failing myocytes isolated from a transaortic con-
striction mouse model, the adrenergic stimulation–induced 
cAMP activity is reduced at the PM11 and the SR,12 consistent 
with depressed PKA phosphorylation of PLB.13 In contrast, 
much less is known about the regulation of PKA activity and 
PKA phosphorylation of substrates on the myofilaments dur-
ing cardiac remodeling and disease development. A disturbed 
PKA phosphorylation of myofilament proteins such as TnI 
and myosin-binding protein C alters their calcium-binding 
sensitivity, which directly contributes to inotropic and lusi-
tropic dysfunction in the heart.14
Here, we develop a novel genetically encoded PKA bio-
sensor that is anchored on the myofibrils to probe PKA activi-
ty in cardiac myocytes from a rabbit hypertrophic heart failure 
model.15 Our data show that although the β1AR-induced PKA 
signal is detected at the myofilaments, the sarcolemma, and 
the SR in healthy myocytes, the β2AR-induced PKA signal is 
restricted along the sarcolemma and the SR and does not have 
access to the myofilaments. However, in hypertrophic fail-
ing rabbit myocytes, stimulation of β2AR promotes a strong 
PKA activity at the myofilaments. The emerging β2AR signal 
is associated with downregulation of caveolin-3 in hypertro-
phic failing myocytes, a key structural protein of caveolae that 
confines the β2AR signal.16 Thus, in failing myocytes, stimu-
lation of the β2AR promotes strong PKA activity and PKA 
phosphorylation of TnI. Moreover, we demonstrate that re-
introduction of caveolin-3 normalizes the distribution of the 
β-adrenergic signal and restores contractile response to adren-
ergic stimulation.
Methods
Experimental Animals, Cardiac Myocyte Isolation, 
and Culture
The animal care and experimental protocols followed US National 
Institutes of Health guidelines and were approved by the Institutional 
Animal Care and Use Committees of the University of California at 
Davis. Heart failure (HF) was induced in New Zealand White rab-
bits by combined aortic insufficiency and stenosis as previously 
described.15
Fluorescence Resonance Energy Transfer 
Measurements
Images were acquired using a Leica DMI3000B inverted fluores-
cence microscope (Leica Biosystems, Buffalo Grove, IL) with a 40× 
oil-immersion objective lens and a charge-coupled device camera 
controlled by Metafluor software (Molecular Devices, Sunnyvale, 
CA). Fluorescence images for fluorescence resonance energy transfer 
(FRET) analysis were obtained as described previously.17
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 software 
(La Jolla, CA).
Expanded methods can be found online (Online Data Supplement).
Results
Novel Biosensors Reveal Highly Localized β2AR-
Induced PKA Activity That Does not Reach the 
Myofilaments in Healthy Rabbit Cardiac Myocytes
To analyze the dynamics of PKA activity on the myofilaments, 
we took a novel strategy to anchor FRET-based A-kinase 
activity reporter 3 (AKAR3)17 onto the myofilaments by 
linking AKAR3 to the C terminus of troponin T (myofila-
ment-AKAR3; Figure 1A). Myofilament-AKAR3 was used 
together with 2 other targeted PKA biosensors developed 
previously: PM-AKAR3 is linked to a PM-targeting sequence 
from Kras and SR-AKAR3 is linked to the transmembrane 
domain of PLB.10,18 Confocal analysis of rabbit adult cardiac 
myocytes shows that the biosensors display proper subcellular 
distribution, colocalizing with specific markers for subcellular 
organelles (Figure 1B). The introduction of biosensors does 
not affect adrenergic stimulation–induced PKA phosphoryla-
tion of endogenous TnI (Figure 1C) or PLB.10,18 These data 
indicate that the molecular pathways are preserved on the ex-
pression of biosensors, and the targeted probes are suitable for 
analysis of PKA activity in the microdomains of adult cardiac 
myocytes.
We further characterized the AKAR3 biosensors in re-
sponse to a set of incremental doses of β-adrenergic agonist 
isoproterenol in adult rabbit myocytes. Stimulation of myo-
cytes with isoproterenol induces dose-dependent increases 
in FRET ratio of the PM-, SR-, and myofilament-anchored 
AKAR3 biosensors, and the maximal responses are high-
er at the PM than those at the SR and myofilament (Figure 
1D; Online Figure I). The responses of PM-AKAR3 are also 
more sensitive to isoproterenol stimulation than those of SR-
AKAR3 and myofilament-AKAR3 (Figure 1D and 1E; Online 
Figure I). These data are consistent with previous studies 
showing that PKA phosphorylation of substrates at the PM is 
Nonstandard Abbreviations and Acronyms
AKAR A-kinase activity reporter
βAR β adrenergic receptor
C3SD scaffolding domain of caveolin-3
FRET fluorescence resonant energy transfer
HF heart failure
ISO isoproterenol
PDE phosphodiesterase
PKA protein kinase A
PLB phospholamban
PM plasma membrane
SR sarcoplasmic reticulum
TnI troponin I
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Figure 1. Generation of cardiac myofilament-targeted fluorescence resonant energy transfer (FRET) biosensors. A, Schematic 
representation of subcellular localized protein kinase A (PKA) A-kinase activity reporter 3 (AKAR3) biosensors. Yellow (YFP) and cyan 
(CFP) fluorescent proteins flank a PKA substrate and a forkhead-associated (FHA) domain that recognizes the phosphorylated PKA 
substrate. AKAR3 is linked to a Kras-derived sequence for plasma membrane (PM-AKAR3) localization, to a phospholamban (PLB)-
derived sequence for sarcoplasmic reticulum (SR-AKAR3) localization, and to troponin T for myofilament (MF-AKAR3) localization. 
B, Representative confocal images of biosensor (green) expressed in young rabbit cardiac myocytes. Cells are immunostained with 
subcellular specific markers (red) for the SR (ryanodine receptor [RyR]), the PM (wheat germ agglutinin [WGA]), and (Continued )
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more sensitive to lower doses of isoproterenol stimulation than 
those at the intracellular compartments.19 The isoproterenol-
induced maximal responses are not because of saturation of 
individual biosensors because cotreatment of myocytes with 
forskolin and IBMX (3-isobutyl-1-methylxanthine) induces 
higher increases in FRET ratios of biosensors than those in-
duced by isoproterenol, respectively (Figure 1F). Notably, the 
isoproterenol-induced maximal responses in these localized 
biosensors are equivalent when normalized by those induced 
by cotreatment of forskolin and IBMX (Figure 1G), suggest-
ing that these biosensors are functionally comparable in re-
sponse to adrenergic stimulation in rabbit myocytes.
To analyze the alteration of local PKA dynamics at the 
myofilaments in failing heart, we used cardiac myocytes iso-
lated from rabbits with hypertrophic HF induced by combined 
aortic insufficiency and stenosis.15 Myocytes from age-matched 
rabbits with sham surgery (SHAM) were used as controls. In 
age-matched SHAM myocytes, stimulation of the βAR with 
a saturated dose of isoproterenol (100 nmol/L) leads to an in-
crease of PKA activity, which is completely blocked by β1AR 
selective antagonist CGP20712A but not by β2AR selective 
antagonist ICI118551 (Figure 2A). Accordingly, stimulation 
of SHAM myocytes with isoproterenol significantly promotes 
PKA phosphorylation of TnI at serine 23/24, which is also 
blocked by CGP20712A but not by ICI118551 (Figure 2B). 
However, stimulation with isoproterenol promotes a stronger 
PKA activity associated with the myofilaments in failing myo-
cytes than SHAM cells (Figure 2C and 2D). Notably, stimula-
tion of the β2AR also induces a strong increase in PKA activity 
in failing myocytes (Figure 2C and 2D). Consistent with the 
FRET measurement of PKA activity, stimulation of the β2AR 
promotes a strong increase in PKA phosphorylation of TnI in 
HF myocytes but not in SHAM controls (Figure 2E). These 
data indicate that in HF myocytes, the β2AR gains an ability to 
promote a strong PKA signal on the myofilaments.
βAR-Induced PKA Activity Is Diminished at the SR 
and the PM in Failing Rabbit Myocytes
We also examined the alteration of local PKA dynamics at 
the SR in failing myocytes, an important intracellular organ-
elle that regulates calcium signaling for myocyte contraction. 
In SHAM myocytes, stimulation of the βAR promotes a sig-
nificant increase in PKA activity at the SR, which is inhibited 
by β1AR antagonist CGP20712A but not by β2AR antagonist 
ICI118551 (Figure 3A). Consistent with the FRET-based mea-
surement of PKA activity, stimulation of SHAM myocytes 
with isoproterenol promotes PKA phosphorylation of PLB at 
serine 16, which is completely blocked by CGP20712A but 
not by ICI118551 (Figure 3B). However, stimulation with iso-
proterenol promotes a weaker PKA activity at the SR in failing 
myocytes than that in SHAM cells (Figure 3C and 3D). Further 
analysis reveals that the β1AR-induced PKA activity at the SR 
is reduced, whereas the β2AR-induced PKA activity at the SR 
is slightly increased (Figure 3C and 3D). Consistently, the ad-
renergic-induced PKA phosphorylation of PLB is diminished 
in HF myocytes compared with those in SHAM controls. In 
both SHAM and HF cells, the β1AR acts as the primary recep-
tor subtype in adrenergic stimulation (Figure 3E). These data 
indicate that in HF myocytes, the βAR-induced PKA activity is 
diminished at the SR for substrate phosphorylation.
In comparison, stimulation of βAR promotes a robust in-
crease in PKA activity at the PM in SHAM myocytes, which 
is significantly decreased in HF myocytes (Figure 4A through 
4C). Inhibition of either β1AR with CGP20712A or β2AR with 
ICI118551 attenuates PKA activity induced by isoproterenol, 
with a stronger inhibition by the β1AR blocker CGP20712A 
(Figure 4B). Further analysis reveals that the reduced adren-
ergic response at the PM in HF myocytes is primarily because 
of a diminished β1AR-stimulated PKA activity (Figure 4A and 
4D). These data suggest that the βAR-induced PKA activity is 
diminished at the PM in failing myocytes.
Redistribution of Phosphodiesterase Activity 
Contributes to Elevated PKA Activity on the 
Myofilaments in Failing Heart
Recent studies have also revealed essential roles of alteration in 
phosphodiesterase (PDE) expression in remodeling of adrener-
gic signal in HF myocytes.11,20 We next studied the involvement 
of various cAMP PDEs on the modification of local PKA ac-
tivity in HF myocytes. In SHAM myocytes, inhibition of PDE3 
with cilostamide induces a strong increase in PKA activity at 
the myofilaments and the SR but not at the PM (Figure 5A 
through 5C). In comparison, inhibition of PDE4 with rolip-
ram induces a strong response in PKA activity at the PM and, 
to a lesser extent, at the myofilaments and the SR (Figure 5D 
through 5F). Consistent with these observations, PDE3 dis-
plays colocalization with the myofilament-binding protein ac-
tin, whereas both PDE4D and PDE4B display colocalization 
with the PM marker caveolin-3 (Online Figure II). In HF myo-
cytes, the myofilament-associated PDE3 activity is decreased 
(Figure 5A and 5G), whereas the PM-associated PDE3 activity 
is increased relative to SHAM controls (Figure 5C and 5I), sug-
gesting a shifted distribution of PDE3 activity from the myofil-
aments to the sarcolemma. In comparison, the PM-associated 
PDE4 activity in HF myocytes is decreased relative to SHAM 
controls (Figure 5F and 5I). Meanwhile, inhibition of PDE4 
induces a small increase in PKA activity at the SR in SHAM 
myocytes, which is enhanced in HF cells (Figure 5E and 5H). 
However, the SR-associated PDE3 activity is not significantly 
altered in HF cells (Figure 5B and 5H). In addition, inhibition 
Figure 1 Continued. the MF (phalloidin). Merge images confirm colocalization of fluorescent signals. C, Immunoblot analyses of 
PKA phosphorylation of troponin I (TnI) at serine 23/24 in response to isoproterenol (ISO) stimulation (1 or 100 nmol/L) in young 
rabbit myocytes infected with MF-AKAR3 probes. D, Young rabbit myocytes expressing PM-AKAR3, SR-AKAR3, and MF-AKAR3 are 
stimulated with a set of incremental doses of ISO. Time courses show AKAR3 FRET responses after stimulation with ISO.  
E, Normalized, isoproterenol-induced, dose–response curves of AKAR3 biosensors (EC50 PM-AKAR3 at 2.16×10−10 mol/L, SR-AKAR3 
at 2.57×10−9 mol/L, and MF-AKAR at 3.89×10−9 mol/L). F, Maximal increases in AKAR3 FRET ratio after stimulation with ISO (1 µmol/L) 
or after cotreatment with forskolin (10 µmol/L) and IBMX (3-isobutyl-1-methylxanthine; 100 µmol/L). G, Normalized maximal FRET 
responses of individual AKAR3 biosensors against the increases induced by cotreatment with forskolin and IBMX, respectively. SERCA 
indicates sarco/endoplasmic reticulum Ca2+-ATPase.
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of PDE2 with erythro-9-(2-hydroxy-3-nonyl)adenine induces 
a small increase in PKA activity at the PM and myofilaments in 
SHAM myocytes; the erythro-9-(2-hydroxy-3-nonyl)adenine–
induced response is increased at the PM in HF cells, whereas 
the erythro-9-(2-hydroxy-3-nonyl)adenine–induced response 
is reduced at the myofilaments in HF cells (Online Figure III). 
Although the PDE2 activity at the SR is minimal in SHAM 
myocytes, it is increased in HF cells (Online Figure III).
Together, in healthy rabbit myocytes, the PKA activity 
at the PM is under predominant control of PDE4, whereas 
PDE3 hydrolyzes preferentially a pool of cAMP in the vicin-
ity of the myofilaments (Figure 5). In HF rabbit myocytes, 
the presence of PDE4 activity at the PM is reduced, whereas 
the activity of PDE3 and PDE2 become more prominent. 
In contrast, the activity of PDE3 and PDE2 is decreased at 
the myofilaments (Figure 5; Online Figure III). These data 
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Figure 2. A highly localized β2 adrenergic receptor (β2AR) signal is not accessible to the myofilaments (MF) in SHAM rabbit cardiac 
myocytes. A, SHAM rabbit cardiac myocytes expressing MF-AKAR3 are stimulated with 100 nmol/L ISO (total), or in the presence 
of 100 nmol/L β2AR blocker ICI118551 (β1AR) or 300 nmol/L of the β1AR blocker CGP20712A (β2AR). The maximal increases in MF-
AKAR3 are plotted in bar graph. The dash line indicates the maximal increases induced by forskolin (10 μmol/L) and IBMX (3-isobutyl-1-
methylxanthine; 100 μmol/L). ***P<0.01 by 1-way ANOVA followed by post hoc Bonferroni test. B, Stimulation of SHAM cardiac myocytes 
with isoproterenol (ISO) in the presence of CGP20712A or ICI118551 for 5 minutes. The PKA phosphorylation of troponin I (TnI) at Ser 
23/24 is detected in Western blot, and the increases in phosphorylation of TnI are plotted in bar graph. N=6, **P<0.01 by 1-way ANOVA 
followed by post hoc Bonferroni test. C, Time courses of fluorescence resonant energy transfer (FRET) responses are from SHAM and 
heart failure (HF) cardiac myocytes expressing MF-A-kinase activity reporter 3 (AKAR3) after stimulation of βARs. D, Bar graph represents 
the maximal increases in MF-AKAR3 FRET ratio in (C). *P<0.05 and ***P<0.001 by Student t test. E, Stimulation of SHAM and HF cardiac 
myocytes with ISO in the presence of CGP20712A or ICI118551 for 5 min. The PKA phosphorylation of TnI at Ser 23/24 is detected in 
Western blot and quantified in bar graph. N=6, **P<0.01 by 1-way ANOVA followed by post hoc Bonferroni test.
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indicate dysregulation of these hydrolytic enzymes in HF 
myocytes. Accordingly, Western blotting analysis shows a 
reduction of PDE3 and an upregulation of PDE4 expression 
in left ventricles after HF (Figure 6A). Moreover, PDE4 is 
shifted to internal compartments, whereas PDE3 is enriched 
at the sarcolemma region in HF myocytes relative to SHAM 
controls (Online Figure IV). The membrane-enriched PDE3 
does not colocalize with β2AR in HF myocytes (Online 
Figure IV). Therefore, in HF myocytes, PDEs may not be 
effectively coupled to adrenergic receptors. Indeed, although 
inhibition of PDE4 and PDE3 potentiates adrenergic stimu-
lation–induced PKA phosphorylation of TnI in SHAM myo-
cytes, the effects of these PDE inhibitors are diminished in 
the HF cells (Online Figure V).
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Figure 3. Diminished β adrenergic receptor (βAR)–induced protein kinase A (PKA) activity at the sarcoplasmic reticulum (SR) in 
failing cardiac myocytes. A, SHAM rabbit cardiac myocytes expressing SR-A-kinase activity reporter 3 (AKAR3) are stimulated with 
100 nmol/L isoproterenol (ISO) (total), or in the presence of 100 nmol/L β2AR blocker ICI118551 (β1AR) or 300 nmol/L of the β1AR blocker 
CGP20712A (β2AR). The maximal increases in SR-AKAR3 are plotted in bar graph. The dashed line indicates the maximal increases 
induced by forskolin (10 μmol/L) and IBMX (3-isobutyl-1-methylxanthine; 100 μmol/L). **P<0.01 when compared with total by 1-way 
ANOVA followed by post hoc Bonferroni test. B, Stimulation of SHAM cardiac myocytes with ISO in the presence of CGP20712A or 
ICI118551 for 5 minutes. The PKA phosphorylation of phospholamban (PLB) at serine 16 is detected in Western blot and plotted in bar 
graph. N=6, **P<0.01 by 1-way ANOVA followed by post hoc Bonferroni test. C, Time courses of fluorescence resonant energy transfer 
(FRET) responses are from SHAM and heart failure (HF) cardiac myocytes expressing SR-AKAR3 after stimulation of βARs. D, Bar graph 
represents the maximal increases in SR-AKAR3 FRET ratio in (C). *P<0.05 by Student t test. E, Stimulation of SHAM and HF cardiac 
myocytes with ISO in the presence of CGP20712A or ICI118551 for 5 min. The PKA phosphorylation of PLB is detected in Western blot 
and quantified in bar graph. N=6, **P<0.01 and ***P<0.001 by 1-way ANOVA followed by post hoc Bonferroni test.
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In a separate set of experiments, we applied PKA inhibi-
tors in the FRET measurement to assess the baseline sub-
cellular PKA activity in HF and SHAM myocytes (Online 
Figure VI). In SHAM myocytes, we detect a significant re-
duction of PKA activity by H89 at the myofilaments and the 
SR but minimal change in PKA activity at the PM (Online 
Figure VI). In HF myocytes, the H89-senstive PKA activity 
at the PM and the SR does not change (Online Figure VI). 
However, the H89-senstive PKA activity at the myofilaments 
is increased in HF cells, indicating an elevation of baseline 
PKA activity associated with myofilaments in HF myocytes 
(Online Figure VI).
Reintroduction of Caveolin-3 Restores Distribution 
of βAR-Induced PKA Signal, PKA Phosphorylation, 
and Contractility in Failing Myocytes
β2AR is enriched in the caveolae of cardiac myocytes, 
which confines the receptor action to the local PM domains. 
Disruption of caveolae leads to enhanced β2AR stimulation 
of ion channels at the PM.16,21 Previous studies have demon-
strated that the expression of caveolin-3 is decreased in differ-
ent mouse and human cardiac diseases including heart failure 
and hypertrophy.22–24 Loss of caveolin-3 is associated with re-
distribution of β2AR signal on the PM in failing myocytes.25 
Here, we reveal an 80% reduction of protein expression of 
caveolin-3 in the failing rabbit myocytes. This reduction is 
associated with an increase of PKA phosphorylation of TnI 
(Figure 6A). Caveolin-3 has a scaffolding domain (C3SD) that 
is critical for the structure and function of caveolae. A mem-
brane-permeable peptide corresponding to C3SD modulates 
β2AR regulation of L-type calcium channel.21 We applied the 
membrane-permeable C3SD peptide to healthy rabbit myo-
cytes to examine whether inhibition of caveolin-3 promotes 
β2AR signal to the myofilaments. Treatment with C3SD sig-
nificantly enhances β2AR-induced PKA activity at the myo-
filaments but not at the SR (Figure 6B and 6C). In contrast, 
a scrambled peptide does not enhance β2AR-induced PKA 
activity at the myofilament. Consistent with the FRET-based 
measurement of PKA activity, C3SD significantly promotes 
β2AR-induced PKA phosphorylation of TnI at the myofila-
ments (Figure 6D). These data suggest that caveolin-3 plays 
an essential role in preventing the β2AR from signaling to the 
myofilaments; therefore, loss of caveolin-3 in HF myocytes 
may permit β2AR to signal to the myofilaments to increase 
PKA activity and substrate phosphorylation.
We sought to restore the expression of caveolin-3 in hy-
pertrophic failing myocytes and to evaluate βAR signaling 
and PKA activity on the myofilaments. Reintroduction of 
caveolin-3 partially restores the distribution of PDEs (Online 
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Figure 4. Redistribution of β adrenergic receptor (βAR) subtype activity at the plasma membrane (PM) in failing cardiac myocytes. 
A, SHAM and heart failure (HF) rabbit cardiac myocytes expressing PM-A-kinase activity reporter 3 (AKAR3) are stimulated with 100 
nmol/L isoproterenol (ISO; total), in the presence of 100 nmol/L β2AR blocker ICI118551 (β1AR) or 300 nmol/L of the β1AR blocker 
CGP20712A (β2AR). Time courses show fluorescence resonant energy transfer (FRET) responses from SHAM and HF cardiac myocytes 
expressing PM-AKAR3 after stimulation of βARs. B–D, The maximal increases in PM-AKAR3 in SHAM and HF myocytes are plotted in bar 
graph. In (B), the dash line indicates the maximal increases induced by forskolin (10 μmol/L) and IBMX (3-isobutyl-1-methylxanthine; 100 
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Figure IV) and their activity in HF myocytes, including an 
increase in PDE4 activity at the PM and increases in PDE3 
and PDE2 activity at the myofilaments (Online Figures III and 
VII). Moreover, reintroduction of caveolin-3 partially normal-
izes the distribution of β2AR (Online Figure VIII) and PKA 
activity at the subcellular compartments, including increases 
in PKA activity at the PM and decreases in PKA activity at 
the SR and myofilaments after stimulation with isoproterenol 
(Figure 7A through 7C). Although the β1AR-induced PKA ac-
tivity is increased at the PM, the β2AR-induced PKA activity 
is decreased throughout the myocytes. Notably, after reintro-
duction of caveolin-3, the β2AR-induced PKA activity does 
not reach the myofilaments; instead, it is confined to the PM 
and the SR (Figure 7A through 7C). Accordingly, the phos-
phorylation of TnI under β2AR stimulation in failing myocytes 
is significantly diminished after overexpression of caveolin-3 
(Figure 7D). Finally, overexpression of caveolin-3 restores β-
adrenergic–induced contractile shortening response in hyper-
trophic failing rabbit myocytes (Figure 7E).
Discussion
The cardiac PKA activity is fine-tuned to ensure co-ordinated 
phosphorylation of substrates in different compartments for 
excitation–contraction coupling at baseline and after adrener-
gic stimulation. In this study, we have revealed a structural–
functional remodeling in hypertrophic failing rabbit myocytes 
that links the redistribution of βAR signal to enhanced PKA 
phosphorylation of myofilament proteins (Figure 8). Although 
the β2AR-induced signal is restricted along the sarcolemma 
and the SR in healthy myocytes, an augmented β2AR signal 
associated with loss of caveolin-3 is selectively directed to the 
myofilaments in hypertrophic failing cells. This augmented 
β2AR signal, together with reduced PDE activity associated 
with myofibrils, promotes strong PKA activity and PKA phos-
phorylation of the myofilament protein TnI in hypertrophic 
failing myocytes. Moreover, reintroduction of caveolin-3 is 
able to normalize the distribution of adrenergic signaling and 
restores contractile response to adrenergic stimulation in hy-
pertrophic failing rabbit myocytes.
A tonic PKA activity is maintained by adenylyl cyclase–
dependent cAMP production and PDE-dependent cAMP 
hydrolysis.19,26 Our results show that PDE4 is the major en-
zyme that controls local PKA activity along the sarcolemma, 
whereas PDE3 mediates primarily cAMP hydrolysis on the 
myofilaments (Figure 5). In agreement, both PDE4D and 
PDE4B display overlap with the membrane marker caveo-
lin-3 (Online Figure II), consistent with a recent report show-
ing that both enzymes have a binding motif to caveolin-3;27 
loss of caveolin-3 may lead to loss of PDE4 activity at the 
sarcolemma. In contrast, PDE3 displays a colocalization with 
myofibrils (Online Figure II), supporting its primary role in 
controlling local cAMP and PKA activity there (Figure 5). 
Meanwhile, we observe a high tonic PKA activity on the 
myofilaments, which is consistent with a relatively high PKA 
phosphorylation of myosin-binding protein C and TnI in 
healthy cardiac tissues.28
Although the PKA activity is usually depressed in 
the late stage of human heart failure,29,30 there are reports 
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Figure 5. Redistribution of 
phosphodiesterase (PDE) activity in 
failing cardiac myocytes. A–F, SHAM 
and heart failure (HF) rabbit cardiac 
myocytes expressing MF-A-kinase 
activity reporter 3 (AKAR3), SR-AKAR3, 
or PM-AKAR3 are treated with 10 μmol/L 
rolipram (PDE4) or 1 μmol/L cilostamide 
(PDE3). Time courses of fluorescence 
resonant energy transfer (FRET) traces 
from SHAM and HF cardiac myocytes 
are shown. G–I, The maximal increases 
in AKAR3 FRET ratio in SHAM and 
HF myocytes are plotted in bar graph. 
*P<0.05 and ***P<0.001 by Student t 
test.
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showing preserved or elevated PKA phosphorylation on TnI 
and PLB.31,32 It is not completely understood how the cellu-
lar PKA activity in myocytes evolves during the course of 
heart failure development. Here, we observe a redistribution 
of PKA activity in hypertrophic failing myocytes, including 
an increased PKA activity at the myofilaments. In agreement, 
a recent report also shows that PKA phosphorylation of myo-
filament proteins is elevated in the spontaneous hypertensive 
rat model.33 It is therefore possible that PKA activity is redis-
tributed as part of the remodeling of βAR signaling during 
the compensatory stage before a general depression of PKA 
activity at the late stage of heart failure. In a classic view, βARs 
are desensitized in HF due in part to the reduced β1AR density 
at the cell surface,34 rendering the heart unable to respond to 
catecholamine stimulation.6 However, recent progress sug-
gests that βARs can continuously signal at the cell surface7 
and after catecholamine-induced endocytosis.8 Studies show 
that βARs are accumulated at the endosome under chronic 
elevation of sympathetic activity in HF.35 These βARs may 
signal from endosomes, offering a potential mechanism on re-
distribution of PKA activity from the PM to the myofilaments 
in failing myocytes (Figures 2 and 4). Further analysis reveals 
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Figure 6. Inhibition of caveolin-3 promotes adrenergic signaling on the myofilaments in heart failure (HF) cardiac myocytes.  
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that the diminished β1AR signaling contributes to lower PKA 
activity at the sarcolemma (Figure 4), which is consistent with 
previous observations that β1AR density is downregulated in 
this rabbit HF model.36 In comparison, β2AR density is not 
reduced;36 rather an augmented β2AR signal may be preferen-
tially directed to the myofilaments. Moreover, the shifted PKA 
activity can be further exacerbated by relocation of PDE3 and 
PDE2 activity away from the myofilaments to the sarcolemma 
(Figure 5; Online Figure III). Together, these observations 
suggest that the βAR signal undergoes relocation intracellular-
ly during the development of heart failure. Further studies will 
likely yield novel information on βAR-PKA signal remodel-
ing in subcellular compartments in models of cardiac disease, 
which may offer insight into cardiac hypertrophic remodeling 
and compensatory contractility in the heart.
Detubulation and loss of caveolae are two prominent fea-
tures during cardiac structural remodeling; these alterations 
can in turn promote signal remodeling in cardiac myocytes. 
Although the β2AR is confined in the tubular region in healthy 
myocytes, chemical disruption of caveolae with a cholesterol-
depleting agent, methyl-β-cyclodestrin, results in >60% in-
crease in β2AR-dependent PKA phosphorylation of PLB and 
TnI, as well as lusitropic responses in adult myocytes.37 In ad-
dition, a membrane-permeable peptide representing the C3SD 
leads to reduction of β2AR-dependent PKA phosphorylation 
of L-type calcium channel at the PM.21 Detubulation and loss 
of caveolae in hypertrophic failing myocytes isolated from a 
mouse model yield broad distribution of β2AR signaling along 
the PM crest.25,37 The loss of close proximity of β2AR to caveo-
lin-3–associated PDE427 can also permit a much broader reach 
of receptor signaling outside of the T-tubular region in failing 
cells.25 In this study, we have observed an amplified β2AR sig-
nal to the myofilaments after treatment with C3SD to promote 
PKA phosphorylation of TnI. Together, these observations 
suggest that inhibition of caveolin-3 leads to a signal shift from 
the PM to intracellular compartments. Moreover, we observed 
an amplified β2AR signal associated with loss of caveolin-3 in 
failing rabbit myocytes, which preferentially propagates to-
ward the myofilaments (Figures 2 and 6). These data, for the 
first time, link the redistribution of β2AR to amplified PKA sig-
nal at the myofilaments in failing myocytes. Furthermore, rein-
troduction of caveolin-3 in HF myocytes can increase caveolae 
density,38 which may facilitate the development and extension 
of T-tubules39 and enrichment of β2AR to the T-tubule (Online 
Figure VIII). Reintroduction of caveolin-3 may also recruit 
PDE4 enzymes to the proximity of the β2AR local domain27 
(Online Figures II and IV) to confine β2AR signals in local sub-
cellular environments.25,40 Consequently, reintroduction of ca-
veolin-3 effectively prevents β2AR from sending a signal to the 
myofilaments in rabbit failing myocytes and from promoting 
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Figure 7. Expression of caveolin-3 
normalizes adrenergic signaling on the 
myofilaments (MFs) in heart failure (HF) 
cardiac myocytes. A–C, SHAM or HF 
myocytes expressing MF-A-kinase activity 
reporter 3 (AKAR3), PM-AKAR3, or SR-
AKAR3 together with caveolin-3 as indicated. 
Myocytes are stimulated with 100 nmol/L 
isoproterenol (ISO), or in the presence of 100 
nmol/L ICI118551 or 300 nmol/L CGP20712A. 
The maximal increases in fluorescence 
resonant energy transfer (FRET) ratio are 
plotted in bar graph. *P<0.05, **P<0.01, and 
***P<0.001 by 1-way ANOVA followed by 
post hoc Bonferroni test. D, HF myocytes 
expressing caveolin-3 are stimulated with 
100 nmol/L ISO in the presence of 300 
nmol/L CGP20712A. PKA phosphorylation 
of troponin I at serine 23/24 are detected in 
Western blots and quantified in bar graph. 
N=5; *P<0.01 by 1-way ANOVA followed by 
post hoc Bonferroni test. E, SHAM and HF 
rabbit myocytes with or without expression 
of caveolin-3 are stimulated with ISO (100 
nmol/L). Myocyte contractile shortening is 
plotted as bar graphs. *P<0.05 by 1-way 
ANOVA followed by post hoc Bonferroni test.
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PKA phosphorylation of TnI (Figure 8). Moreover, reintroduc-
tion of caveolin-3 could normalize the functional relationship 
between βAR and the L-type Ca2+ channel at both T-tubules and 
caveolae.16,21 As a result, the caveolin-3–expressing myocytes 
become more responsive to adrenergic stimulation to enhance 
contractility (Figure 7). Together, these data support the notion 
that caveolin-3 is essential in regulation of compartmented car-
diac βAR signaling.25,40
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Figure 8. Schematic models on changes 
of local protein kinase A (PKA) signal 
in failing cardiac myocytes. In SHAM 
cardiac myocytes, β1AR has a higher 
and further reaching response in all 3 
subcellular compartments tested than 
β2AR. β2AR generates a highly localized 
response within the plasma membrane 
(PM) and the sarcoplasmic reticulum (SR) 
but does not induce any significant PKA 
activity on the myofilaments (MFs). PKA 
activity at the PM microdomain is under 
predominant control of PDE4, whereas 
PDE3 preferentially hydrolyzes a pool of 
cAMP in the vicinity of MFs. In HF myocytes 
with reduced caveolin-3, the β adrenergic 
receptor (βAR)–induced PKA activity at the 
PM and, to a lesser extent, at the SR is 
reduced. However, the βAR-induced PKA 
activity at the myofilament is increased 
due in part to augmented β2AR signal and 
miss-localization of PDE3 away from the 
myofilaments. Reintroduction of caveolin-3 
normalizes the distribution of βAR-induced 
PKA activity at the subcellular compartments, 
including increases in PKA activity at the PM 
and decreases in PKA activity at the MFs. 
In particular, the β2AR-induced PKA activity 
is confined to the PM and the SR and does 
not access the myofilaments. PDE indicates 
phosphodiesterase; PLB, phospholamban; 
RyR, ryanodine receptor; and SERCA, sarco/
endoplasmic reticulum Ca2+-ATPase.
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Together, this study reveals that structural remodeling 
leads to βAR signal remodeling in failing myocytes, which 
yields a decrease in PKA activity at the PM and an increase 
in β2AR-PKA activity and phosphorylation of substrates on 
the myofilaments in hypertrophic rabbit hearts. Our study sug-
gests caveolin-3 as an essential regulator of subcellular adren-
ergic signal at the myofilaments in myocytes.
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What Is Known?
•	 Abnormal protein kinase A phosphorylation of substrates on myofila-
ments directly contributes to inotropic and lusitropic dysfunction in 
heart failure (HF).
•	 Adrenergic signaling is altered in HF myocytes, including downregula-
tion of β
1
 adrenergic receptor (β
1
AR)-induced signals and an increase 
in the β
2
AR-induced signal.
What New Information Does This Article Contribute?
•	 In HF myocytes, β
1
AR-induced signaling is selectively downregulated 
at the sarcolemma, whereas β
2
AR-induced signaling gains access to 
myofilament.
•	 Reintroduction of caveolin-3 in HF myocytes prevents β
2
ARs from 
sending signal to myofilaments for substrate phosphorylation.
•	 Reintroduction of caveolin-3 normalizes βAR-induced contractile re-
sponses in HF myocytes.
These studies reveal that βAR signaling undergoes remodeling 
in HF myocytes, which shifts the protein kinase A activity from 
the cell surface to the intracellular compartments including the 
sarcoplasmic reticulum and myofilaments. In particular, β
2
AR-
induced signals gain access to the myofilament, which contrib-
utes to abnormal protein kinase A phosphorylation of troponin I 
and contractile dysfunction. Preclinical studies to assess the ef-
fects of inhibition of β
2
AR signal on HF are indicated.
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Supplement Materials. 
 
Online expanded Methods 
 
Development of PKA FRET-based biosensor and adenovirus construction
The regular PKA activity biosensor AKAR31 was linked to the C-terminus of cardiac troponin T 
(provided by Dr. Jianpin Jin, Wayne State University, OH) to generate a myofilament-anchored 
AKAR3, termed MF-AKAR3.  The recombinant construct in pcDNA3.1 (Invitrogen, CA, USA) 
was verified by DNA sequencing. MF-AKAR3 cDNA was subsequently subcloned into a shuttle 
vector pAdTrack-CMV to generate recombinant adenovirus according to the manufacturer’s 
instructions (Quantum Biotechnologies,Republic of South Africa). The PM-AKAR3 and SR-
AKAR3 have been reported previously.2, 3 
 
Experimental animals, cardiac myocyte isolation and culture 
The animal care and experimental protocols followed US National Institutes of Health guidelines 
and were approved by the Institutional Animal Care and Use Committees of the University of 
California at Davis.  HF was induced in New Zealand White rabbits by combined aortic 
insufficiency and stenosis as previously described. HF progression was monitored by 
echocardiography and myocytes were isolated 7.1±1.9 months after aortic constriction when left 
ventricle end-systolic dimension exceeded 1.4 cm. Briefly, rabbits were sacrificed under general 
anesthesia (induction with propofol 2 mg/kg followed by 2-5% isoflurane in 100% oxygen). After 
thoracotomy, the heart was quickly excised and rinsed in cold nominally Ca-free MEM. The right 
atrium was removed and the aorta opened to visualize the left coronary ostia which was then 
cannulated using a 4F catheter.5 Perfusion of the left ventricle and left atrium was established 
before removal of the right ventricle free wall and application of a purse-string suture to secure 
the catheter in place. The remainder of the isolation procedure was then essentially as previously 
described.6  
 
For myocyte cultures, cells were plated on natural mouse laminin (Life Technologies, Grand 
Island, NY) coated dishes in culture medium PC-1 (Lonza Walkersville, MD, USA) 
supplemented with 1% Penicillin-Streptomycin, PH 7.4, filtered) and infected, when specified, 
with PM-AKAR3, SR-AKAR3, or MF-AKAR3 biosensor together with GFP-caveolin-3 or 
caveolin-3 for at least 28 hours. 
 
Immunostaining 
Confocal microscopy was performed using Zeiss LSM700 microscope (Zeiss, Pleasanton, CA) 
equipped with a Plan-Apochromat 63X oil-immersion objective. For co-localization experiments, 
cells were fixed for 15 min with PFA 4%, rinsed 3 times with PBS and permeabilized with 
blocking solution (0.5% NP40, 2% goat serum) for 15 min.  Cells were then washed and stained 2 
hours with anti-RyR antibody (obtained from the DSHB, the University of Iowa, IA), anti-
caveolin-3 (BD, NJ, USA #610420), anti-PDE3 (a gift from Yan Chen, University of Rochester) 
anti-PDE4B (a gift from Marco Conti, University of California at San Francisco) antibodies, anti-
PDE4D (Ab14613) (Abcam, Cambridge, UK) followed by 1 hour of the secondary anti-mouse or 
anti-rabbit Alexa Fluor® 488 antibodies (A-21063 and A-11055, respectively) (Thermo Fisher, 
MA, USA), or followed by Phalloidin Alexa Fluor® 568 Conjugate (A-12380) or Wheat Germ 
Agglutinin, Alexa Fluor® 555 Conjugate (W32464) (Thermo Fisher, MA, USA). 
 
Western blotting  
Left ventricular extracts or isolated cardiac myocytes were prepared in lysis buffer (25mM Tris 
HCl PH 7.6, 150 mM NaCl, 1% IGEPAL, 1% Sodium deoxycholate, 0.1% SDS, 1mM EDTA) 
with protease and phosphatase inhibitors (Na3F 100mM, Na2VO4 1mM, glycerol 1mM, NaP2O7 
2.5 mM, leupeptin 10 μg/ml, PMSF 1mM, aprotinin 10 μg/ml), and protein concentration was 
measured by BCA assay (Pierce, IL). Lysates were resolved by SDS-PAGE before being 
transferred onto a PVDF membrane (Merck Millipore ltd. MA, USA) and incubated overnight 
with primary antibodies followed by IRDye 680CW or 800CW secondary antibodies and 
acquired with an Odyssey scanner (LI-COR Biosciences Lincoln, NE, USA). The primary 
antibodies used for Western blotting were as follows: anti-β2AR (sc-570) (SCBT, TX, USA), 
anti-PDE3A (1098-1115, NIH), anti-PDE4D (Ab14613) (Abcam, Cambridge, UK) anti-phospho-
PLB (Ser16, Badrilla), anti-PLB (MA3-922) (Affinity Bioreagent, CO, USA), anti-phospho-
troponin I (Ser23/24, #4004) and anti-troponin I (#4002) (Cell Signaling, MA, USA). Signal 
intensity was quantitated by Image Studio software version 2.1 (LI-COR Biosciences Lincoln, 
NE, USA).   
 
Fluorescence resonance energy transfer (FRET) measurements  
Images were acquired using a Leica DMI3000B inverted fluorescence microscope (Leica 
Biosystems, Buffalo Grove, IL) with a 40X oil-emersion objective lens and a charge-coupled 
device camera controlled by Metafluor software (Molecular Devices, Sunnyvale, CA). 
Fluorescence images were recorded by exciting the donor fluorophore at 430-455 nm and 
measuring emission fluorescence with two filters (475DF40 for cyan and 535DF25 for yellow). 
Images were subjected to background subtraction, and were acquired every 20 seconds with 
exposure time of 200 ms. The donor/acceptor FRET ratio was calculated and normalized to the 
ratio value of baseline. The binding of cAMP to AKAR3 increases CFP/YFP FRET ratio.1 
 
Adult cardiomyocyte contractility  
Fresh isolated adult cardiomyocytes were infected with GFP or GFP-caveolin-3 adenovirus for 18 
hours. Cells were then placed in a dish with 3 ml beating buffer (NaCl 120 mM, KCl 5.4 mM, 
NaH2PO41.2mM, MgSO41.2 mM, HEPES 20mM, Glucose 5.5 mM, CaCl21mM, PH 7.1, 
filtered). Cells were paced at 1 Hz with voltage of 30 V using a SD9 stimulator (Grass 
Technology, Warwick, RI). Contractile shortening of myocytes were recorded on an inverted 
microscope (Zeiss AX10) at 20X magnification using Metamorph software (Molecular Devices, 
Sunnyvale, CA) with the following settings: 40 frames per second for 5 seconds, at an interval of 
1 minute for a duration of 10 minutes. Isoproterenol (100 nM) was added into the dish after two 
movies were acquired. The percentage of myocyte fractional shortening (FS) was calculated as 
(maximal cell length – minimal cell length)/ maximal cell length * 100%. Analysis was 
performed using Metamorph.  
 
Statistical analysis  
All data were expressed as mean ± SEM. Statistical analysis was performed using GraphPad 
Prism 6 software (La Jolla, CA). The sample size for each group was shown in the figure legends. 
The cells were from at least three sets of independent experiments. Differences between two 
groups were evaluated by 2-tailed Student’s t-test; comparisons of multiple groups were 
performed using one-way ANOVA followed by post hoc Bonferroni test. p < 0.05 was defined as 
statistically significant. 
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Supplemental Figure legend 
 
Supplemental Figure I. Dose-dependent increases in AKAR3 FRET biosensors after stimulation 
of βAR in young adult rabbit myocytes. Rabbit myocytes expressing PM-AKAR3, SR-AKAR3, 
and MF-AKAR3 are stimulated with increasing doses of ISO. The maximal increases in different 
doses of ISO are plotted as dose response curves for individual biosensors, respectively.  
 
Supplemental Figure II. Distribution of PDEs in SHAM and HF rabbit cardiac myocytes 
Immunostaining shows distribution between PDE4B or PDE4D (red) and caveolin-3 (green), and 
between PDE3A (green) and the myofilaments (phalloidin, red) in healthy, HF, or HF myocytes with 
caveolin-3 expression.  
 
Supplemental Figure III. Redistribution of PDE2 activity in HF rabbit cardiac myocytes 
Quantification of the maximal changes in FRET ratio in SHAM and HF myocytes with or without 
expression of caveolin-3. Cells expressing PM-AKAR3, SR-AKAR3 or MF-AKAR are stimulated 
with the PDE2 selective inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, 1 μmol/L). * p < 
0.05 and ** p < 0.01 by one-way ANOVA followed by post hoc Bonferroni test.  
 
Supplemental Figure IV. Distribution of PDEs in SHAM and HF rabbit cardiac myocytes A and 
B) Immunostaining shows distribution between PDE4D (red) and caveolin-3 (green), and between 
PDE3A (green) and the myofilaments (phalloidin, red) in SHAM, HF, or HF myocytes with caveolin-
3 expression. C) HF rabbit myocytes expressing flag-β2AR are fixed for immunostaining to show 
distribution of between β2AR and PDE3A or PDE4D.  
 
Supplemental Figure V. PDE regulates PKA-mediated phosphorylation of myofilaments in 
SHAM and HF rabbit cardiac myocytes. Immunoblots show PKA phosphorylation of TnI in 
SHAM or HF cells after stimulation with ISO (100 nmol/L, 5 min) in the presence of PDE2 inhibitor 
 
(EHNA 1 μmol/L), PDE3 inhibitor cilostamide (Cilo, 100 nmol/L), or PDE4 inhibitor Rolipram (Roli, 
100 nmol/L). Bar graphs show mean ± SEM, N = 4, * p < 0.05 by one-way ANOVA followed by post 
hoc Bonferroni test. 
 
Supplemental Figure VI. Detection of baseline PKA activity at the subcellular compartments in 
SHAM and HF rabbit myocytes. Data shows quantification of the maximal changes in FRET ratio 
in SHAM and HF rabbit myocytes. A) Young adult myocytes expressing MF-AKAR3 are stimulated 
with ISO (100 nmol/L) in the presence of PKA inhibitor myr-PKI (10 μmol/L), KT5720 (10 μmol/L) 
or H89 (10 μmol/L). *** p < 0.001 by one-way ANOVA followed by post hoc Bonferroni test. B) 
SHAM and HF rabbit myocytes expressing PM-AKAR3, SR-AKAR3 or MF-AKAR are treated with 
PKA inhibitor H89 (10 μmol/L). * p < 0.05 by student’s t-test. 
 
Supplemental Figure VII. Caveolin 3 modulates subcellular distribution of PDE3 and PDE4 
activity in HF rabbit cardiac myocytes. Data shows quantification of the maximal changes in FRET 
ratio in SHAM myocytes and HF myocytes with or without expression of caveolin-3. Cells expressing 
PM-AKAR3 or MF-AKAR are treated with PDE3 selective inhibitor cilostamide (Cilo, 1 μmol/L) or 
PDE4 selective inhibitor Rolipram (Roli, 10 μmol/L). * p < 0.05 by student’s t-test. 
 
Supplemental Figure VIII. Localization of β2AR and caveolin-3 in HF rabbit cardiac myocytes. 
HF rabbit myocytes expressing flag-β2AR alone (lower panels) or together with caveolin-3 (upper 
panels) are fixed for immunostaining to show distribution of β2AR and caveolin-3.  
 
 
 

 
-11 -10 -9 -8 -7 -6
0.9
1.0
1.1
1.2
1.3
1.4
1.5
PM
SR
MF
Y
FP
/C
FP
Supplemental Figure I
Cav3
Cav3
Merge
Merge
PDE4B
PDE4D
PDE3A MergePhalloidin
Supplemental Figure II
1.00
1.05
1.10
SHAM
HF
HF + Cav
PM MF SR
 Y
FP
/C
FP
Supplemental Figure III
* * ** **
*
PDE2 inhibition
15
22 15
19
159
20
23
Supplemental Figure IV
A
SHAM
HF
HF +
Cav3
PDE4D Cav3 Merge
CB
SHAM
HF
HF + Cav3
PDE3A Phalloidin Merge
PDE3A Mergeb2AR
PDE4D Mergeb2AR
Supplemental Figure IV Continued 
HF
HF
Supplemental Figure V
pTnI 
TnI
pT
nI
/T
nI
 (A
U
)
0.0
0.5
1.0
1.5
2.0
ISO + + + +
+
+
+
ISO + + + +
+
+
+
*
*
SHAM
HF
Supplemental Figure VI
PDE4 inh
PDE3 inh
PDE2 inh
PDE4 inh
PDE3 inh
PDE2 inh
0.0
0.5
1.0
1.5
2.0
pT
nI
/T
nI
 (A
U
)
1.00
0.95
0.90
0.85
1.00
1.05
1.10
1.15
1.20
FSK
PKI 
H-89
KT5720
+ + + +
- + - -
- - + -
- - - +
MF
YF
P/
C
FP
Y
FP
/C
FP
B
as
el
in
e 
P
K
A
 a
ct
iv
ity
PM MFSR
SHAM
HF
H89 + + + + + +
*
***
***
***
A B
20 17
19 21 28
20
22
17
19
41
pTnI 
TnI
Cav3 O.E.
Cav3
Merge
Merge
`2-AR
`2-AR
Supplemental Figure VIII
MF A B
Supplemental Figure VII
* **
 Y
FP
/C
FP
 
PDE3 inhPDE4 inh
PM 
1.00
1.05
1.10
1.15
1.00
1.05
1.10
1.15
PDE3 inhPDE4 inh
**
SHAM
HF
HF+Cav3
22
9
14
29
9
12
22
5
14 6
12
14
 Y
FP
/C
FP
 
